Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

Name: Pivotal bioVenture Partners Investment Advisor LLC Q2 2026 13F Filing | 13F Explorer
Creator: Pivotal bioVenture Partners Investment Advisor LLC
Published: 2026-08-13

Location: San Francisco, CA

CIK: 0001844645 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 13, 2026

Total Value: $308M (100.0% shares, 0.0% debt)

Holdings (13)

New Positions (1)

AVLN AVALYN PHARMACEUTICALS INC 10.3%

Value $31.83M Shares 966,792 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
AVLN	AVALYN PHARMACEUTICALS INC	966,792	$31.83M	10.3%	—	—	COM SHS	05348Y105

Increased Positions (3)

TRVI TREVI THERAPEUTICS INC 10.6%

Value $32.5M (+75.3%) Shares 1,742,672 (+12.2%) Est. Cost — Unrealized —

AVTX AVALO THERAPEUTICS INC 2.6%

Value $8.021M (+81.5%) Shares 434,033 (+46.7%) Est. Cost — Unrealized —

PCVX VAXCYTE INC 26.9%

Value $82.86M (+3.9%) Shares 1,425,470 (+3.9%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
TRVI	TREVI THERAPEUTICS INC	1,742,672 (+12.2%)	$32.5M (+75.3%)	10.6%	—	—	COM	89532M101
AVTX	AVALO THERAPEUTICS INC	434,033 (+46.7%)	$8.021M (+81.5%)	2.6%	—	—	COM NEW	05338F306
PCVX	VAXCYTE INC	1,425,470 (+3.9%)	$82.86M (+3.9%)	26.9%	—	—	COM	92243G108

Exited Positions (1)

BOLT BOLT BIOTHERAPEUTICS INC 0.1%

Value $172K Shares 42,581 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BOLT	BOLT BIOTHERAPEUTICS INC	42,581	$172K	0.1%	—	—	—	097702203

Decreased Positions (3)

OCS OCULIS HOLDING AG 6.8%

Value $20.89M (-53.2%) Shares 1,506,250 (-10.4%) Est. Cost — Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 10.8%

Value $33.18M (+3.9%) Shares 1,265,283 (-6.7%) Est. Cost — Unrealized —

ZBIO ZENAS BIOPHARMA INC 4.0%

Value $12.46M (+7.6%) Shares 490,766 (-17.1%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
OCS	OCULIS HOLDING AG	1,506,250 (-10.4%)	$20.89M (-53.2%)	6.8%	—	—	ORDINARY SHARES	H5870P102
ARQT	ARCUTIS BIOTHERAPEUTICS INC	1,265,283 (-6.7%)	$33.18M (+3.9%)	10.8%	—	—	COM	03969K108
ZBIO	ZENAS BIOPHARMA INC	490,766 (-17.1%)	$12.46M (+7.6%)	4.0%	—	—	COM	98937L105

Unchanged Positions (6)

EVMN EVOMMUNE INC 8.3%

Value $25.61M Shares 1,926,943 Est. Cost — Unrealized —

MPLT MAPLIGHT THERAPEUTICS INC 7.1%

Value $21.91M Shares 611,446 Est. Cost — Unrealized —

BIOA BIOAGE LABS INC 5.2%

Value $16.01M Shares 653,374 Est. Cost — Unrealized —

RLYB RALLYBIO CORP 1.6%

Value $4.809M Shares 300,579 Est. Cost — Unrealized —

IMNM IMMUNOME INC 5.0%

Value $15.52M Shares 732,512 Est. Cost — Unrealized —

RXRX RECURSION PHARMACEUTICALS IN 0.7%

Value $2.186M Shares 595,518 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
EVMN	EVOMMUNE INC	1,926,943	$25.61M	8.3%	—	—	COM SHS	30054Y107
MPLT	MAPLIGHT THERAPEUTICS INC	611,446	$21.91M	7.1%	—	—	COM	56565P103
BIOA	BIOAGE LABS INC	653,374	$16.01M	5.2%	—	—	COM	09077V100
RLYB	RALLYBIO CORP	300,579	$4.809M	1.6%	—	—	COM	75120L209
IMNM	IMMUNOME INC	732,512	$15.52M	5.0%	—	—	COM	45257U108
RXRX	RECURSION PHARMACEUTICALS IN	595,518	$2.186M	0.7%	—	—	CL A	75629V104